NYSE: ANVSAnnovis Bio Inc Stock Ownership - Who owns Annovis Bio?
Insider buying vs selling
Have Annovis Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew Walsh | Vice President Finance | 2025-06-16 | 500 | $2.90 | $1.45kBuy |
| Michael B. Hoffman | Director | 2025-06-13 | 25,000 | $2.80 | $70.00kBuy |
| Michael B. Hoffman | Director | 2025-06-13 | 1 | $2.83 | $2.83Buy |
| Reid McCarthy | Director | 2025-06-10 | 2,000 | $2.95 | $5.90kBuy |
| Marialuisa MacCecchini | President CEO | 2025-06-04 | 46,000 | $3.37 | $155.02kBuy |
| Michael B. Hoffman | Director | 2025-05-29 | 5,000 | $2.43 | $12.15kBuy |
ANVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANVS insiders and whales buy or sell their stock.
ANVS Shareholders
What type of owners hold Annovis Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Michael B. Hoffman | 8.57% | 1,669,641 | $4.52M | Insider |
| Marialuisa MacCecchini | 5.72% | 1,114,459 | $3.02M | Insider |
| Vanguard Group Inc | 3.33% | 647,920 | $1.76M | Institution |
| Two Sigma Investments LP | 0.85% | 166,219 | $450.45k | Institution |
| Ubs Group Ag | 0.83% | 160,876 | $435.97k | Institution |
| Geode Capital Management LLC | 0.78% | 152,613 | $413.58k | Institution |
| Susquehanna International Group LLP | 0.66% | 127,705 | $346.08k | Institution |
| Blackrock Inc | 0.52% | 100,629 | $272.70k | Institution |
| Merit Financial Group LLC | 0.50% | 97,816 | $265.08k | Institution |
| Jr Robert M. Whelan | 0.49% | 95,700 | $259.35k | Insider |
ANVS vs Biotech Stocks
Annovis Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.